• Assessment of benefits and risks of probiotics in baby foods Bifidobacterium lactis Bb12. 

      Halvorsen, Ragnhild; Narvhus, Judith; Lassen, Jørgen Fr; Midtvedt, Tore; Rugtveit, Jarle; Yazdankhah, Siamak Pour; Andersen, Lene Frost; Frølich, Wenche; Frøyland, Livar; Haugen, Margaretha; Høiby, Anne; Kapperud, Georg; Lunestad, Bjørn Tore; Meltzer, Helle Margrete; Nesbakken, Truls; Nygård, Karin Maria; Robertson, Lucy; Olsvik, Ørjan; Paulsen, Jan Erik; Tranulis, Michael A.; Tryland, Morten; Rimstad, Espen (Research report; Forskningsrapport, 2010-05-14)
      The Norwegian Scientific Committee for Food Safety (VKM) has appointed an ad hoc-group of experts to answer a request from the Norwegian Food Safety Authority regarding benefit and risk assessment of B. lactis Bb12 in baby foods focusing on the age groups 4-6 months, 6-12 months and 1-3 years. This assessment is based on the literature provided by the notifier as well as that found by a MEDLINE search.
    • Plasma Fatty Acid Ratios Affect Blood Gene Expression Profiles - A Cross-Sectional Study of the Norwegian Women and Cancer Post-Genome Cohort 

      Olsen, Karina Standahl; Fenton, Christopher Graham; Frøyland, Livar; Waaseth, Marit; Paulssen, Ruth H; Lund, Eiliv (Journal article; Tidsskriftartikkel; Peer reviewed, 2013)
      High blood concentrations of n-6 fatty acids (FAs) relative to n-3 FAs may lead to a “physiological switch” towards permanent low-grade inflammation, potentially influencing the onset of cardiovascular and inflammatory diseases, as well as cancer. To explore the potential effects of FA ratios prior to disease onset, we measured blood gene expression profiles and plasma FA ratios (linoleic ...
    • Risk assessment on use of Lactobacillus rhamnosus (LGG) as an ingredient in infant formula and baby foods (II) 

      Rimstad, Espen; Andersen, Lene Frost; Frølich, Wenche; Frøyland, Livar; Halvorsen, Ragnhild; Høiby, Ernst Arne; Kapperud, Georg; Lunestad, Bjørn Tore; Lassen, Jørgen Fredrik; Meltzer, Helle Margrete; Narvhus, Judith Ann; Nygård, Karin; Nesbakken, Truls; Olsvik, Ørjan; Paulsen, Jan Erik; Robertson, Lucy Jane; Tranulis, Michael A.; Tryland, Morten; Vainio, Kirsti; Haugen, Margaretha (Research report; Forskningsrapport, 2007-06-15)
      On 10. March 2006 , The Norwegian Food Safety Authority (Mattilsynet) decided that, on the basis of VKM’s previous risk assessment (2005), Nutramigen 1 with Lactobacillus rhamnosus GG (LGG) could not be marketed in Norway as medical foods for infants (0-4 months). In addition, The Norwegian Food Safety Authority (Mattilsynet) decided (08. November ...